Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

A New Drug Application has been accepted seeking accelerated approval for dordaviprone for patients with recurrent H3 ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Precigen on Tuesday said a green light would make PRGN-2012 the only FDA-approved therapeutic for the treatment of adults with the disorder, which is a lifelong neoplastic disease of the upper and ...

Australian biotech Telix Pharmaceuticals (NASDAQ:TLX) announced late Tuesday that the U.S. Food and Drug Administration (FDA) has accepted its marketing application for TLX250-CDx and granted it ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food ...

Insmed Incorporated (NASDAQ: INSM) announced on February 24, 2025 that the U.S. Food and Drug Administration (FDA) does not ...

The $149 Satechi 6-Port Charging Station can output 200W over multiple USB-C ports, although not as intelligently as the ...

Lynn Dekleva, who recently took a senior role at the agency, once led an aggressive effort by industry to block regulations ...

Education spokeswoman Sarah Henderson said a Coalition government would impose tougher caps on international and hold a zero ...

The Trump administration is ending support for a New York State project, unfinished after nine years in development, that is ...